Schizophrenia Home > Invega Sustenna Injectable

An injectable medication, Invega® Sustenna® (paliperidone palmitate) is a long-acting drug licensed to treat schizophrenia. This medicine comes in the form of a liquid that is given as an injection into a muscle (an intramuscular, or IM, injection). It is usually given every four weeks and will be administered by a healthcare provider in an office or clinic.
The first two Invega Sustenna injections are given into the shoulder (deltoid muscle). Subsequent injections can be given in the buttocks (gluteal muscle) or shoulder.
(For more details on this medicine, click Invega Sustenna. This Web selection provides a complete overview of this drug, including how it works, possible side effects, and what to discuss with your healthcare provider before beginning treatment.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.